New Perspective on How Genes are Turned on and Off

Answer to decades-long mystery could play a part in cancer and other human diseases.

New study has identified a key factor that partially unravels nucleosomes and clears the way for genes to activate. The study led by postdoctoral researcher Jia Fei in James Kadonaga's lab at the University of California San Diego is published in the journal Genes & Development.

Until human genes are activated, they are blocked by structures known as nucleosomes, components that serve to package DNA inside cells.

A Guide to CRISPR Gene Activation by Wyss Institute
The CRISPR-Cas9 system has come to be known as the quintessential tool that allows researchers to edit the DNA sequences of many organisms and cell types.

‘Nucleosome destabilizing factor, or NDF, activates genes by destabilizing nucleosomes, clearing the way for genes to activate.’

For the past several decades, scientists have been trying to determine how these nucleosome roadblocks clear out to allow genes to be turned on. The identification of "NDF," or nucleosome destabilizing factor, provides a new perspective on how genes are turned on and off--knowledge useful in the study of human diseases such as cancer, which can be caused by improper gene activity.

"It's a special privilege to discover a new activity in the regulation of our genes," said Kadonaga, adding that the breakthrough came as a result of Fei's interest in factors that might disassemble or destabilize nucleosomes. "This novel approach led to the identification of NDF as a nucleosome destabilizing factor."

Genes are special functional segments in our DNA, which is a long molecular chain of genetic instructions. When genes are turned on, an enzyme named RNA polymerase travels along the DNA and makes a working copy (RNA) of the DNA. Here, nucleosomes, which look like beads on the DNA chain, pose a problem as they block the passage of the polymerase. This led to the question: How is the polymerase able to travel through nucleosomes?

Gene Therapy to Repair Damaged Hearts
Gene therapy aims to correct the most common complication following a heart attack, arrhythmias.

The answer emerged with the identification of NDF, which destabilizes nucleosomes and enables the progression of the polymerase. The researchers say NDF's makeup suggests that it is broadly used in perhaps all human cells and may play a role in disease.

"NDF is present at abnormally high levels in breast cancer cells, and the overproduction of NDF might be partly responsible for the uncontrolled growth of these cells," said Kadonaga, Distinguished Professor of Molecular Biology and the Amylin Endowed Chair in Lifesciences Education and Research. "Thus, the identification of NDF resolves an old mystery and reveals a new factor that may have an important role in many aspects of human biology."

Computer Algorithm Can Reveal Gene Networks Activated in Cancer Cell
Computer algorithm called ALPACA can reveal which gene networks are activated in a diseased cell that can be useful in developing new strategies that can help prevent or cure disease like cancer.

Kadonaga said the research was a collaborative effort with UC San Diego colleagues Bing Ren and Christopher Glass, "and exemplifies the friendly, collegial and interactive nature of our campus."

Gene Therapy for Lipoprotein Lipase Deficiency Effective and Safe
Study reports that the first patient who received gene therapy for lipoprotein lipase deficiency tolerated the treatment well.

Source-Eurekalert